ProKidney approaches pivotal research, funding crossroads for drug therapy
· richard craver staff reporter; richard craver
AI Briefing
- ProKidney's drug therapy aims to delay kidney transplant need for patients
- Rilparencel-based treatment being developed
- Pivotal research could revolutionize organ transplantation
Advertisement